|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Evaluation of ORF-1658, a new formulation for sequential oral contraceptive |
| Fertility and Sterility 19(3): 390-404. 1968. |
| The effectiveness and safety of a new sequential oral contraceptive formulation was evaluated. The subjects |
| received 14 80 mcg tablets of mestranol followed by 6 tablets of 2 mg 3-desoxyacetoxymethyl progesterone (ORF- |
| 1658) plus mestranol. The overall pregnancy rate was .25 + or - .24/100 woman-years of exposure. The |
| discontinuation rate for drug-related reasons was 2.5%. Amenorrhea (6.3%), headache (5.2%), and dizziness (3.4%) |
| were the most commonly reported side effects. This sequential therapy is recommended over the combined therapy |
| regimen because of a lower incidence of irregular bleeding, premenstrual tension syndrome, and increased weight |
| gain. However, in cases of menorrhagia or dysmenorrhea, the combined therapy is recommended. (PubHealth.info |
| Document ID: CONT9T 1018-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Evaluation of ORF-1658, a new formulation for sequential |
| oral contraceptive therapy.", is(are) Rovinsky JJ. The source of this article is "Fertility and Sterility 19(3): 390-404. |
| 1968.". This article was published in 1968 in English language(s). (PubHealth.info® Document ID: CONT9T 1018- |
| 06. All rights reserved with PubHealth.info) PIN: 41018 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |